Cabrellis Pharmaceuticals Corporation
Closed- Headquarters
- San Diego, California
- Business Model
- B2B
About
Cabrellis Pharmaceuticals Corporation was a clinical-stage private oncology company dedicated to the development of amrubicin, a third-generation synthetic anthracycline that was in advanced Phase II development for small cell lung cancer (SCLC) in North America and the European Union. Pharmion Corporation acquired Cabrellis Pharmaceuticals in November 2006, gaining US and European rights to amrubicin as part of the transaction.
Summary
Cabrellis Pharmaceuticals Corporation is a Biotech company based in San Diego, United States.
Funding History
Nov 2006
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cabrellis-pharmaceuticals-corporation"><img src="https://indexed.vc/api/badge/company/cabrellis-pharmaceuticals-corporation" alt="Cabrellis Pharmaceuticals Corporation on Indexed.vc" width="260" height="76" /></a>